Dear Patient, Peter Mac is working closely with the Victorian Department of Health and Human Services to keep safe and protect our patients and their families & carers, visitors and health care workers from COVID-19. Our hospital remains open and fully functional with the appropriate safeguards...
A team of Peter Mac researchers, led by A/Prof Paul Ekert, have been awarded a Cancer Council Victoria Venture Grant to look into a potential new approach to treating childhood cancers.
The American Society for Clinical Oncology has included the findings of a trial co-led by Peter Mac investigators into a new treatment approach for head and neck cancers in its annual review of major advances against cancer.
Six Victorian Cancer Agency Research Fellowships have been awarded to Peter Mac early- and mid-career scientists, supporting research into key areas including the development of predictive biomarkers for therapy response and resistance, new cancer treatments and the integration of exercise into cancer care.
Peter Mac’s Prof Mark Dawson has been named the 2020 recipient of the McCulloch & Till Award from the International Society for Experimental Haematology – the first time an Australian has received the honour.
Peter Mac welcomes today’s announcements that will enable Australia’s first on-shore commercial manufacture of CAR T-Cell therapy, and lead to wider subsidised access to this treatment.